Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Areca catechu extract is a botanical extract derived from the seeds (nuts) of the Areca catechu palm, commonly known as betel nut. It contains a variety of bioactive compounds, including alkaloids (most notably arecoline), polyphenols (catechins, procyanidins, quercetin), and tannins. The extract is used traditionally in Ayurvedic and folk medicine as a stimulant, antiparasitic, digestive aid, and astringent. **Mechanisms of action** may involve cholinergic stimulation via muscarinic receptors (arecoline acts as a muscarinic agonist), antimicrobial activity through phenolic content, antioxidant activity due to polyphenols, and potential pro-apoptotic effects on immune cells. There is evidence for immunomodulatory, antimicrobial, antioxidant, and possible anticancer activities in vitro and in animal studies. Abuse and chronic use are associated with dependence, oral mucosal diseases, and increased cancer risk, particularly oral and esophageal cancer. Areca catechu extract is not approved by the FDA for any medical use and is classified as unsafe for human consumption. Currently, its primary approved medicinal use is in veterinary practice as an anthelmintic agent[1][2][6][13][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on areca catechu extract.